van Beest Paul A, Hofstra Jorrit J, Schultz Marcus J, Boerma E C, Spronk Peter E, Kuiper Michael A
Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Crit Care. 2008;12(2):R33. doi: 10.1186/cc6811. Epub 2008 Mar 4.
Low mixed or central venous saturation (S(c)vO2) can reveal global tissue hypoxia and therefore can predict poor prognosis in critically ill patients. Early goal directed therapy (EGDT), aiming at an ScvO2 >/= 70%, has been shown to be a valuable strategy in patients with sepsis or septic shock and is incorporated in the Surviving Sepsis Campaign guidelines.
In this prospective observational multi-center study, we determined central venous pressure (CVP), hematocrit, pH, lactate and ScvO2 or SvO2 in a heterogeneous group of critically ill patients early after admission to the intensive care units (ICUs) in three Dutch hospitals.
Data of 340 acutely admitted critically ill patients were collected. The mean SvO2 value was > 65% and the mean ScvO2 value was > 70%. With mean CVP of 10.3 +/- 5.5 mmHg, lactate plasma levels of 3.6 +/- 3.6 and acute physiology, age and chronic health evaluation (APACHE II) scores of 21.5 +/- 8.3, the in-hospital mortality of the total heterogeneous population was 32.0%. A subgroup of septic patients (n = 125) showed a CVP of 9.8 +/- 5.4 mmHg, mean ScvO2 values of 74.0 +/- 10.2%, where only 1% in this subgroup revealed a ScvO2 value < 50%, and lactate plasma levels of 2.7 +/- 2.2 mmol/l with APACHE II scores 20.9 +/- 7.3. Hospital mortality of this subgroup was 26%.
The incidence of low ScvO2 values for acutely admitted critically ill patients is low in Dutch ICUs. This is especially true for patients with sepsis/septic shock.
低混合静脉血氧饱和度(S(c)vO2)或中心静脉血氧饱和度可提示全身组织缺氧,因此可预测危重症患者的不良预后。早期目标导向治疗(EGDT)旨在使ScvO2≥70%,已被证明是脓毒症或脓毒性休克患者的一项有价值的治疗策略,并被纳入《拯救脓毒症运动指南》。
在这项前瞻性观察性多中心研究中,我们在荷兰三家医院的重症监护病房(ICU)收治危重症患者后早期测定了不同类型危重症患者的中心静脉压(CVP)、血细胞比容、pH值、乳酸及ScvO2或SvO2。
收集了340例急性收治的危重症患者的数据。平均SvO2值>65%,平均ScvO2值>70%。平均CVP为10.3±5.5 mmHg,血浆乳酸水平为3.6±3.6,急性生理与慢性健康状况评分系统(APACHE II)评分为21.5±8.3,全部不同类型患者的院内死亡率为32.0%。脓毒症患者亚组(n = 125)的CVP为9.8±5.4 mmHg,平均ScvO2值为74.0±10.2%,该亚组中只有1%的患者ScvO2值<50%,血浆乳酸水平为2.7±2.2 mmol/l,APACHE II评分为20.9±7.3。该亚组的医院死亡率为26%。
荷兰ICU中急性收治的危重症患者ScvO2值低的发生率较低。脓毒症/脓毒性休克患者尤其如此。